Capital Research Global Investors Takes Position in Medline $MDLN

Capital Research Global Investors acquired a new stake in Medline (NASDAQ:MDLN) in the 4th quarter, Holdings Channel reports. The firm acquired 14,784,203 shares of the company’s stock, valued at approximately $620,937,000.

Other hedge funds also recently modified their holdings of the company. Sound Income Strategies LLC bought a new stake in shares of Medline in the fourth quarter valued at approximately $25,000. Entrust Financial LLC acquired a new position in shares of Medline in the fourth quarter valued at $26,000. NBC Securities Inc. bought a new position in Medline in the fourth quarter worth $28,000. Global Retirement Partners LLC bought a new position in Medline in the fourth quarter worth $31,000. Finally, North Star Investment Management Corp. bought a new position in Medline in the fourth quarter worth $36,000.

Analyst Ratings Changes

Several brokerages recently commented on MDLN. Deutsche Bank Aktiengesellschaft set a $42.00 target price on Medline in a research report on Thursday, May 7th. Royal Bank Of Canada raised their target price on Medline from $47.00 to $53.00 and gave the stock an “outperform” rating in a research report on Thursday, February 26th. UBS Group raised their target price on Medline from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Thursday, February 26th. Robert W. Baird reduced their target price on Medline from $57.00 to $45.00 and set an “outperform” rating for the company in a research report on Wednesday. Finally, Weiss Ratings cut Medline from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $50.54.

Medline Price Performance

Shares of NASDAQ MDLN opened at $33.61 on Monday. The firm’s fifty day moving average is $41.45. Medline has a 52-week low of $32.81 and a 52-week high of $50.88. The company has a debt-to-equity ratio of 0.65, a current ratio of 4.41 and a quick ratio of 2.51.

Medline (NASDAQ:MDLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.04. The company had revenue of $7.35 billion for the quarter. Medline’s revenue was up 10.7% compared to the same quarter last year. As a group, equities analysts forecast that Medline will post 1.51 earnings per share for the current fiscal year.

Medline Company Profile

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply?chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.